Protease inhibitors for use in the treatment of psoriasis

Details Protease inhibitors for use in the treatment of psoriasis Protease inhibitors for use in the treatment of psoriasis

A - Human Necessities

61

K

A61K 38/57 (2006.01)

Patent

CA 2339485

Psoriasis may be treated by topical administration of a urokinase inhibitor, such as PAI-2, or a combination of protease inhibitors, such as PAI-2 with other serine protease inhibitors and/or with protease inhibitors such as inhibitors of metalloproteinases, acid proteases, and thiol proteases.

On peut traiter le psoriasis par administration topique d'un inhibiteur d'urokinase, tel que le PAI-2, ou d'une combinaison d'inhibiteurs de protéase tels que le PAI-2 avec d'autres inhibiteurs de sérine protéase et/ou avec des inhibiteurs de protéase tels que des inhibiteurs de métalloprotéase, de protéase acide et de protéase à cystéine.

Affiliated with

Also associated with

Rating

Protease inhibitors for use in the treatment of psoriasis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Protease inhibitors for use in the treatment of psoriasis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protease inhibitors for use in the treatment of psoriasis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1523678